ArticleFood science & nutrition2024
Redefining Neonatal Vitamin A Adequacy and Deficiency Based on Maternal Nutrition: A Cross-Sectional Study in Chongqing, China.
Article in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are no established diagnostic criteria for neonatal vitamin A deficiency (VAD), and applying adult VAD criteria to neonates may overestimate the neonatal VAD rate. This study aimed to evaluate neonatal vitamin A (VA) status and redefine thresholds for neonatal VA adequacy and deficiency based on maternal VA nutrition. A cross-sectional study involving 1901 mother-neonate pairs was conducted in Chongqing, China. VA nutritional status was assessed by measuring serum VA levels and dietary VA intake from the third trimester to birth. The VAD rates of maternal dietary intake and serum were 27.091% and 23.356%, respectively, while 88.8% of neonates had serum VA levels < 0.70 μmol/L, the threshold for adult VAD. Neonatal VA levels were significantly lower than maternal levels. All neonates were healthy, with no clinical signs of VAD. Neonatal VA levels correlated positively with maternal VA levels. The threshold for neonatal VA adequacy was estimated to be ≥ 0.489 (95%CI: 0.464-0.512) μmol/L when maternal VA nutrition was adequate, and the 2.5th percentile of VA levels among all neonates was 0.192 μmol/L, predicting neonatal VAD. The study concluded that neonatal VAD rates might be overestimated, as most neonates received adequate VA from their mothers. Maternal VA status is a reliable predictor of neonatal VA status due to their close relationship. This study offers a new perspective on prenatal nutrition for determining neonatal VA adequacy and deficiency thresholds and developing neonatal VA supplementation programs. Further research is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.